iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Apr 24
 -3.98 / -1.08%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.


1 month+2.17% 3 years+44.40%
3 months+12.76% 5 years+32.30%
1 year+58.67% Since inception+9.66%
Data through 04/25/2015

Quote Details

Previous close$367.68
Open day’s range-- – --
Net asset value (NAV)363.72 (04/24/2015)
Daily volume1,186,724
Average volume (3 months)1,693,962
Data as of 04/24/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+32.30%+22.89%
Expense Gross exp ratio0.48%0.47%
Risk 5 year sharpe ratio1.581.48
Net assets$8.4B$1.8B
Average market cap$19.3B$35.3B
Average P/E29.225.2
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BIIB Biogen8.11%
AMGN Amgen7.97%
CELG Celgene7.46%
GILD Gilead Sciences7.45%
REGN Regeneron Pharmaceuticals6.53%
VRTX Vertex Pharmaceuticals Inc3.88%
ALXN Alexion Pharmaceuticals Inc3.78%
ILMN Illumina Inc3.73%
MYL Mylan NV3.31%
BMRN Biomarin Pharmaceutical Inc2.95%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers